首页 > 最新文献

General Thoracic and Cardiovascular Surgery最新文献

英文 中文
Robotic-assisted versus open resection of pulmonary sequestration: a retrospective cohort study. RATS surgery for pulmonary sequestration. 机器人辅助与开放式肺隔离切除术:一项回顾性队列研究。肺隔离的RATS手术。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-01 Epub Date: 2025-06-24 DOI: 10.1007/s11748-025-02172-9
Henrike Deissner, Alessio Campisi, Raffaella Griffo, Benedikt Niedermaier, Thomas Muley, Michael Allgäuer, Hauke Winter, Martin E Eichhorn

Background: Pulmonary sequestration (PS) is a rare congenital lung malformation often requiring surgical resection due to recurrent infections or hemoptysis. Traditionally treated via open thoracotomy, recent advancements have made minimal-invasive approaches like robotic-assisted thoracoscopic surgery (RATS) increasingly viable. This study compares outcomes between RATS and open resection for PS in a high-volume center.

Methods: In this retrospective cohort study, 23 adult patients who underwent surgical resection of PS between 2010 and 2023 were analyzed. Fifteen patients were treated via open thoracotomy (THKT), while eight underwent RATS using the DaVinci-X system. We compared preoperative findings, intraoperative variables, and postoperative outcomes.

Results: The patients in the RATS group were younger (median age: 36 vs 47 years) and had a shorter median hospital stay (5 vs 10 days, p < 0.001) compared to the THKT group. The RATS group also experienced earlier chest drainage removal (3 vs. 4 days, p = 0.016). However, the median duration of surgery was longer for RATS (118 vs. 75 min, p = 0.018). A trend towards less postoperative complications was observed in the RATS group (33% vs. 0%).

Conclusions: RATS provides a safe and effective alternative to open surgery for PS resection, with benefits including reduced hospital stay and earlier chest tube removal. Despite longer operative times, the minimally invasive approach may offer enhanced recovery and fewer complications. Continued accumulation of experience with RATS is likely to improve operative efficiency, making it a valuable option in the surgical management of pulmonary malformations.

背景:肺隔离(PS)是一种罕见的先天性肺畸形,常因反复感染或咯血而需要手术切除。传统上通过开胸治疗,最近的进步使得微创方法如机器人辅助胸腔镜手术(RATS)越来越可行。本研究比较了大容量中心大鼠与开放切除治疗PS的结果。方法:在这项回顾性队列研究中,分析了2010年至2023年接受手术切除PS的23例成人患者。15例患者通过开胸术(THKT)治疗,8例患者使用davincii - x系统进行RATS治疗。我们比较了术前发现、术中变量和术后结果。结果:大鼠组患者更年轻(中位年龄:36 vs 47岁),中位住院时间更短(5 vs 10天)。结论:大鼠组提供了一种安全有效的替代开放手术进行PS切除术的方法,其优点包括缩短住院时间和更早拔除胸管。尽管手术时间较长,但微创入路可提高恢复和减少并发症。RATS的持续经验积累可能会提高手术效率,使其成为肺部畸形手术治疗的一个有价值的选择。
{"title":"Robotic-assisted versus open resection of pulmonary sequestration: a retrospective cohort study. RATS surgery for pulmonary sequestration.","authors":"Henrike Deissner, Alessio Campisi, Raffaella Griffo, Benedikt Niedermaier, Thomas Muley, Michael Allgäuer, Hauke Winter, Martin E Eichhorn","doi":"10.1007/s11748-025-02172-9","DOIUrl":"10.1007/s11748-025-02172-9","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary sequestration (PS) is a rare congenital lung malformation often requiring surgical resection due to recurrent infections or hemoptysis. Traditionally treated via open thoracotomy, recent advancements have made minimal-invasive approaches like robotic-assisted thoracoscopic surgery (RATS) increasingly viable. This study compares outcomes between RATS and open resection for PS in a high-volume center.</p><p><strong>Methods: </strong>In this retrospective cohort study, 23 adult patients who underwent surgical resection of PS between 2010 and 2023 were analyzed. Fifteen patients were treated via open thoracotomy (THKT), while eight underwent RATS using the DaVinci-X system. We compared preoperative findings, intraoperative variables, and postoperative outcomes.</p><p><strong>Results: </strong>The patients in the RATS group were younger (median age: 36 vs 47 years) and had a shorter median hospital stay (5 vs 10 days, p < 0.001) compared to the THKT group. The RATS group also experienced earlier chest drainage removal (3 vs. 4 days, p = 0.016). However, the median duration of surgery was longer for RATS (118 vs. 75 min, p = 0.018). A trend towards less postoperative complications was observed in the RATS group (33% vs. 0%).</p><p><strong>Conclusions: </strong>RATS provides a safe and effective alternative to open surgery for PS resection, with benefits including reduced hospital stay and earlier chest tube removal. Despite longer operative times, the minimally invasive approach may offer enhanced recovery and fewer complications. Continued accumulation of experience with RATS is likely to improve operative efficiency, making it a valuable option in the surgical management of pulmonary malformations.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"80-86"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12789244/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144474821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of ascending aortic length to detect surgical intervention for ascending aortic aneurysms. 升主动脉长度对检测升主动脉瘤手术干预的影响。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-01 Epub Date: 2025-06-25 DOI: 10.1007/s11748-025-02176-5
Toshikuni Yamamoto, Akihiko Usui, Tomonari Uemura, Ryota Yamamoto, Hideki Ito, Tomo Yoshizumi, Sachie Terazawa, Yoshiyuki Tokuda, Yuji Narita, Masato Mutsuga

Objective: Ascending aortic length (AAL) has recently garnered attention as an additional parameter of surgical indication. This study aimed to verify that AAL is extended in ascending aortic aneurysm patients when compared with the normal aorta.

Methods: The study included 132 patients who were diagnosed with true ascending aortic aneurysms from January 2002 to December 2021. The AAL was measured as the distance from the aortic annulus to the origin of the innominate artery. The data of 295 patients who underwent transcatheter aortic valve replacement during same period were compiled as the control group. In order to index AAL, it was divided by the patient's height (Length height index, LHI).

Results: The mean ascending aortic diameter (AAD) and AAL in the 132 patients were 5.3 ± 0.6 cm and 11.7 ± 1.6 cm, respectively. Propensity score matching revealed a significantly longer AAL in the aortic aneurysm group than in the control group (11.7 vs. 8.8 cm, P < 0.05). The LHI in the aortic aneurysm group was significantly greater than in the control group (7.4 vs. 5.7 cm/m, P < 0.05). The relationship between AAD and LHI was analyzed using linear regression analysis. The regression coefficient was 0.59, and the intercept was 4.22. As a tool to predict LHI, the formula: LHI = 0.59 × AAD + 4.22 was obtained.

Conclusions: AAL and LHI were significantly increased in patients with ascending aortic aneurysms. Consequently, LHI may serve as an accurate indicator of surgical intervention.

目的:升主动脉长度(AAL)最近作为手术指征的一个附加参数引起了人们的关注。本研究旨在验证与正常主动脉相比,升主动脉瘤患者的AAL延长。方法:研究纳入2002年1月至2021年12月诊断为真升主动脉瘤的132例患者。AAL是测量从主动脉环到无名动脉起源的距离。选取同期行经导管主动脉瓣置换术的295例患者作为对照组。以AAL除以患者的身高(Length height index, LHI)作为AAL的指标。结果:132例患者平均升主动脉直径(AAD)为5.3±0.6 cm,平均升主动脉直径(AAL)为11.7±1.6 cm。倾向评分匹配显示,主动脉瘤组的AAL明显长于对照组(11.7 cm比8.8 cm), P。结论:升主动脉瘤组的AAL和LHI明显升高。因此,LHI可以作为手术干预的准确指标。
{"title":"Impact of ascending aortic length to detect surgical intervention for ascending aortic aneurysms.","authors":"Toshikuni Yamamoto, Akihiko Usui, Tomonari Uemura, Ryota Yamamoto, Hideki Ito, Tomo Yoshizumi, Sachie Terazawa, Yoshiyuki Tokuda, Yuji Narita, Masato Mutsuga","doi":"10.1007/s11748-025-02176-5","DOIUrl":"10.1007/s11748-025-02176-5","url":null,"abstract":"<p><strong>Objective: </strong>Ascending aortic length (AAL) has recently garnered attention as an additional parameter of surgical indication. This study aimed to verify that AAL is extended in ascending aortic aneurysm patients when compared with the normal aorta.</p><p><strong>Methods: </strong>The study included 132 patients who were diagnosed with true ascending aortic aneurysms from January 2002 to December 2021. The AAL was measured as the distance from the aortic annulus to the origin of the innominate artery. The data of 295 patients who underwent transcatheter aortic valve replacement during same period were compiled as the control group. In order to index AAL, it was divided by the patient's height (Length height index, LHI).</p><p><strong>Results: </strong>The mean ascending aortic diameter (AAD) and AAL in the 132 patients were 5.3 ± 0.6 cm and 11.7 ± 1.6 cm, respectively. Propensity score matching revealed a significantly longer AAL in the aortic aneurysm group than in the control group (11.7 vs. 8.8 cm, P < 0.05). The LHI in the aortic aneurysm group was significantly greater than in the control group (7.4 vs. 5.7 cm/m, P < 0.05). The relationship between AAD and LHI was analyzed using linear regression analysis. The regression coefficient was 0.59, and the intercept was 4.22. As a tool to predict LHI, the formula: LHI = 0.59 × AAD + 4.22 was obtained.</p><p><strong>Conclusions: </strong>AAL and LHI were significantly increased in patients with ascending aortic aneurysms. Consequently, LHI may serve as an accurate indicator of surgical intervention.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"11-16"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12789242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reevaluating echocardiographic indicators in bilateral pulmonary artery banding. 双侧肺动脉束带超声心动图指标的再评价。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-01 Epub Date: 2025-09-30 DOI: 10.1007/s11748-025-02210-6
Muhammet Cihat Çelik, Ömer Burak Çelik, Macit Kalçık

This letter critically examines the recent article by Takei et al., which proposed the velocity ratio (VR) as the most reliable intraoperative echocardiographic indicator for bilateral pulmonary artery banding (BPAB). While this study represents a valuable step toward standardization, its heavy reliance on VR risks overlooking crucial hemodynamic variables. Drawing upon previous literature, this commentary highlights methodological limitations, clinical implications, and the necessity of integrating multiple echocardiographic and hemodynamic parameters. We advocate for a more comprehensive approach that ensures both systemic and pulmonary circulatory stability in congenital heart disease patients.

这封信批判性地审查了Takei等人最近的一篇文章,该文章提出流速比(VR)是双侧肺动脉带(BPAB)最可靠的术中超声心动图指标。虽然这项研究代表了标准化的重要一步,但它对虚拟现实的严重依赖可能会忽视关键的血流动力学变量。根据以前的文献,这篇评论强调了方法学的局限性、临床意义以及综合多种超声心动图和血流动力学参数的必要性。我们提倡一种更全面的方法,以确保先天性心脏病患者的全身和肺循环稳定。
{"title":"Reevaluating echocardiographic indicators in bilateral pulmonary artery banding.","authors":"Muhammet Cihat Çelik, Ömer Burak Çelik, Macit Kalçık","doi":"10.1007/s11748-025-02210-6","DOIUrl":"10.1007/s11748-025-02210-6","url":null,"abstract":"<p><p>This letter critically examines the recent article by Takei et al., which proposed the velocity ratio (VR) as the most reliable intraoperative echocardiographic indicator for bilateral pulmonary artery banding (BPAB). While this study represents a valuable step toward standardization, its heavy reliance on VR risks overlooking crucial hemodynamic variables. Drawing upon previous literature, this commentary highlights methodological limitations, clinical implications, and the necessity of integrating multiple echocardiographic and hemodynamic parameters. We advocate for a more comprehensive approach that ensures both systemic and pulmonary circulatory stability in congenital heart disease patients.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"99-100"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145199022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic-assisted thoracic surgery versus video-assisted thoracic surgery for patients undergoing lung resection: a systematic review and meta-analysis of randomized controlled trials. 肺切除术患者的机器人辅助胸外科手术与视频辅助胸外科手术:随机对照试验的系统回顾和荟萃分析。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-01 Epub Date: 2025-10-02 DOI: 10.1007/s11748-025-02209-z
Francisco Martins Lamas, Gabriele Eckerdt Lech, Laura Roppa Maboni, Pedro Arthur Zimmer Silveira, Pedro Bortoluzzi Escobar da Silva, Arthur Minas Alberti, Natália Vivian Loss, Spencer Marcantonio Camargo, Stephan Adamour Soder

Background: Minimally invasive techniques have mostly replaced open thoracotomy for lung resection, yet their comparative benefits remain unclear. We performed a systematic review and meta-analysis to evaluate clinical outcomes associated with robot-assisted (RATS) and video-assisted thoracic surgery (VATS).

Methods: We searched PubMed, Embase, and Cochrane Central for randomized controlled trials (RCTs) comparing RATS to VATS in patients undergoing lung resection. Primary outcomes were conversion to thoracotomy and overall complications. Risk ratios (RR) and mean differences (MD) were used for categorical and continuous outcomes, respectively, considering as significant p-values < 0.05. Trial sequential analysis was also conducted.

Results: We included five RCTs comprising 712 patients, of whom 338 (47.5%) underwent RATS, and 374 (52.5%) underwent VATS. No differences were found between groups in conversion to thoracotomy (RR 0.65; 95% CI 0.36-1.20; p = 0.17) and overall complications (RR 0.91; 95% CI 0.69-1.21; p = 0.49). RATS presented a higher number of lymph node stations resected (p < 0.00001) and a shorter length of hospital stay after performing sensitivity analysis (p < 0.00001). There were no differences between RATS and VATS in any of the other secondary outcomes.

Conclusion: Our study results reassure the safety and potential benefits associated with RATS lung resections, demonstrating a significantly higher number of lymph node stations resected and a possible trend toward shorter hospital stays, with similar rates of complications and conversion in comparison to VATS.

背景:微创技术大多已取代开胸手术进行肺切除术,但其相对优势尚不清楚。我们进行了系统回顾和荟萃分析,以评估机器人辅助(RATS)和视频辅助胸外科(VATS)相关的临床结果。方法:我们检索了PubMed、Embase和Cochrane Central的随机对照试验(rct),比较大鼠和VATS在肺切除术患者中的疗效。主要结局为转开胸手术和总并发症。风险比(RR)和平均差异(MD)分别用于分类和连续结果,认为p值显著。结果:我们纳入了5项随机对照试验,包括712例患者,其中338例(47.5%)接受了RATS, 374例(52.5%)接受了VATS。两组间转行开胸手术(RR 0.65; 95% CI 0.36-1.20; p = 0.17)和总并发症(RR 0.91; 95% CI 0.69-1.21; p = 0.49)均无差异。结论:我们的研究结果证实了大鼠肺切除术的安全性和潜在益处,表明与VATS相比,大鼠肺切除术的淋巴结数量明显增加,住院时间可能更短,并发症和转归率相似。
{"title":"Robotic-assisted thoracic surgery versus video-assisted thoracic surgery for patients undergoing lung resection: a systematic review and meta-analysis of randomized controlled trials.","authors":"Francisco Martins Lamas, Gabriele Eckerdt Lech, Laura Roppa Maboni, Pedro Arthur Zimmer Silveira, Pedro Bortoluzzi Escobar da Silva, Arthur Minas Alberti, Natália Vivian Loss, Spencer Marcantonio Camargo, Stephan Adamour Soder","doi":"10.1007/s11748-025-02209-z","DOIUrl":"10.1007/s11748-025-02209-z","url":null,"abstract":"<p><strong>Background: </strong>Minimally invasive techniques have mostly replaced open thoracotomy for lung resection, yet their comparative benefits remain unclear. We performed a systematic review and meta-analysis to evaluate clinical outcomes associated with robot-assisted (RATS) and video-assisted thoracic surgery (VATS).</p><p><strong>Methods: </strong>We searched PubMed, Embase, and Cochrane Central for randomized controlled trials (RCTs) comparing RATS to VATS in patients undergoing lung resection. Primary outcomes were conversion to thoracotomy and overall complications. Risk ratios (RR) and mean differences (MD) were used for categorical and continuous outcomes, respectively, considering as significant p-values < 0.05. Trial sequential analysis was also conducted.</p><p><strong>Results: </strong>We included five RCTs comprising 712 patients, of whom 338 (47.5%) underwent RATS, and 374 (52.5%) underwent VATS. No differences were found between groups in conversion to thoracotomy (RR 0.65; 95% CI 0.36-1.20; p = 0.17) and overall complications (RR 0.91; 95% CI 0.69-1.21; p = 0.49). RATS presented a higher number of lymph node stations resected (p < 0.00001) and a shorter length of hospital stay after performing sensitivity analysis (p < 0.00001). There were no differences between RATS and VATS in any of the other secondary outcomes.</p><p><strong>Conclusion: </strong>Our study results reassure the safety and potential benefits associated with RATS lung resections, demonstrating a significantly higher number of lymph node stations resected and a possible trend toward shorter hospital stays, with similar rates of complications and conversion in comparison to VATS.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"1-10"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145206194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver transplant volume association with presence of heart and lung transplant programs: analysis of SRTR metrics. 肝移植容量与心脏和肺移植计划的相关性:SRTR指标的分析。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-01 Epub Date: 2025-07-10 DOI: 10.1007/s11748-025-02178-3
Sanath Patil, Faizaan Siddique, Daler Rahimov, Keshava Rajagopal, John W Entwistle, Adam Bodzin, Vakhtang Tchantchaleishvili

Purpose: We sought to understand how centers transplanting liver only (L0), centers transplanting heart and liver (LH), and centers transplanting liver, heart, and lung (LHL) differ regarding volume, waitlist and post-transplant outcomes.

Methods: Data were collected from the Scientific Registry of Transplant Recipients (SRTR) in July 2023. SRTR star ratings were categorized into five tiers, with one being the lowest tier and five the highest tier.

Results: Median liver transplant volumes were 35 [IQR: 14-51] for L0 centers, 45 [10-75] for LH centers, and 101 [69-131] for LHL centers (p < 0.001). Liver waitlist survival (p = 0.13), waitlist duration (p = 0.31) and 1-year survival ratings (p = 0.32) were comparable across all 3 categories. Annual transplant volume was associated with a higher SRTR waitlist duration rating (p < 0.001) but not with 1-year post-transplant survival (p = 0.51).

Conclusion: The presence of a heart transplant and lung transplant programs in liver transplant centers is associated with higher liver transplant volumes, translating to higher waitlist duration tier ratings for liver recipients, but not to improved 1-year post-transplant survival.

目的:我们试图了解仅肝移植中心(L0)、心脏和肝脏移植中心(LH)和肝脏、心脏和肺移植中心(LHL)在容量、等待名单和移植后结果方面的差异。方法:数据收集于2023年7月的移植受者科学登记处(SRTR)。SRTR星级评级分为五个等级,其中一个是最低的等级,五个是最高的等级。结果:L0中心的中位肝移植量为35 [IQR: 14-51], LH中心为45 [10-75],LHL中心为101 [69-131](p结论:肝移植中心的心脏移植和肺移植项目的存在与更高的肝移植量相关,转化为更高的肝受体等待名单持续时间等级评级,但没有改善移植后1年生存率。
{"title":"Liver transplant volume association with presence of heart and lung transplant programs: analysis of SRTR metrics.","authors":"Sanath Patil, Faizaan Siddique, Daler Rahimov, Keshava Rajagopal, John W Entwistle, Adam Bodzin, Vakhtang Tchantchaleishvili","doi":"10.1007/s11748-025-02178-3","DOIUrl":"10.1007/s11748-025-02178-3","url":null,"abstract":"<p><strong>Purpose: </strong>We sought to understand how centers transplanting liver only (L0), centers transplanting heart and liver (LH), and centers transplanting liver, heart, and lung (LHL) differ regarding volume, waitlist and post-transplant outcomes.</p><p><strong>Methods: </strong>Data were collected from the Scientific Registry of Transplant Recipients (SRTR) in July 2023. SRTR star ratings were categorized into five tiers, with one being the lowest tier and five the highest tier.</p><p><strong>Results: </strong>Median liver transplant volumes were 35 [IQR: 14-51] for L0 centers, 45 [10-75] for LH centers, and 101 [69-131] for LHL centers (p < 0.001). Liver waitlist survival (p = 0.13), waitlist duration (p = 0.31) and 1-year survival ratings (p = 0.32) were comparable across all 3 categories. Annual transplant volume was associated with a higher SRTR waitlist duration rating (p < 0.001) but not with 1-year post-transplant survival (p = 0.51).</p><p><strong>Conclusion: </strong>The presence of a heart transplant and lung transplant programs in liver transplant centers is associated with higher liver transplant volumes, translating to higher waitlist duration tier ratings for liver recipients, but not to improved 1-year post-transplant survival.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"17-22"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144600125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The erector spinae plane block is not superior to perioperative systemic lidocaine infusion for postoperative analgesia management after thoracotomy: a randomized double-blind study. 竖脊肌平面阻滞并不优于围术期全身利多卡因输注用于开胸术后镇痛管理:一项随机双盲研究。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-01 Epub Date: 2025-06-03 DOI: 10.1007/s11748-025-02165-8
Tugberk Küçün, Elif Oral Ahiskalioglu, Ahmet Murat Yayik, Muhammed Enes Aydin, Neslihan Küçün, Ali Bilal Ulas, Ali Ahiskalioglu

Background: The effect of erector spinae plane block and systemic lidocaine infusion for major thoracotomy is still unclear. Therefore, we aimed to compare ESPB, systemic lidocaine and standard analgesia in patients who undergoing major thoracotomy.

Methods: Patients with ASA I-III, aged between 18 and 65 years scheduled for major thoracotomy were enrolled. Patients were randomly assigned to receive an intravenous (IV) infusion of placebo combined with ESP block using placebo (group P), ESP block with 0.25% bupivacaine combined with IV placebo (group ESPB), or IV-lidocaine combined with ESP-block using placebo (group L). The primary outcome was postoperative (24 h) total opioid consumption. The secondary outcomes were VAS scores, rescue analgesia, and intraoperative remifentanil consumption.

Results: Resting VAS scores were significantly lower in both groups ESPB and L compared to group P during the first four postoperative hours. Similarly, dynamic VAS scores were lower in group ESPB and group L compared to group P during the first two postoperative hours (p < 0.05). ESP block was not found to be superior to systemic lidocaine in reducing morphine requirements during the first 24 h (30.25 ± 5.1 vs. 28.7 ± 3.1 respectively, p = 0.567). Additionally, the difference in morphine consumption between group P and either ESP-block or systemic lidocaine groups was minimal, amounting to only 3-4.5 mg. However, the requirement for rescue analgesia was significantly lower in both groups ESPB and L compared to group P (p < 0.05). There was no difference between groups ESPB and L in terms of rescue analgesia requirement.

Conclusion: ESP block did not demonstrate superior postoperative analgesic efficacy compared to systemic lidocaine in patients undergoing major thoracotomy.

背景:竖脊肌平面阻滞和全身利多卡因输注在大开胸手术中的效果尚不清楚。因此,我们的目的是比较ESPB、全身利多卡因和标准镇痛在大开胸手术患者中的应用。方法:纳入ASA I-III型患者,年龄18 ~ 65岁,计划行大开胸手术。患者被随机分配接受静脉(IV)输注安慰剂联合使用安慰剂的ESP阻滞(P组),0.25%布比卡因联合静脉安慰剂的ESP阻滞(ESPB组),或静脉利多卡因联合使用安慰剂的ESP阻滞(L组)。主要终点是术后(24小时)阿片类药物总消耗量。次要结果为VAS评分、抢救镇痛和术中瑞芬太尼用量。结果:术后4小时内,ESPB组和L组的静息VAS评分均明显低于P组。同样,ESPB组和L组在术后2小时内的动态VAS评分低于P组(P)。结论:ESP阻滞在大开胸手术患者的术后镇痛效果与全身利多卡因相比并不明显。
{"title":"The erector spinae plane block is not superior to perioperative systemic lidocaine infusion for postoperative analgesia management after thoracotomy: a randomized double-blind study.","authors":"Tugberk Küçün, Elif Oral Ahiskalioglu, Ahmet Murat Yayik, Muhammed Enes Aydin, Neslihan Küçün, Ali Bilal Ulas, Ali Ahiskalioglu","doi":"10.1007/s11748-025-02165-8","DOIUrl":"10.1007/s11748-025-02165-8","url":null,"abstract":"<p><strong>Background: </strong>The effect of erector spinae plane block and systemic lidocaine infusion for major thoracotomy is still unclear. Therefore, we aimed to compare ESPB, systemic lidocaine and standard analgesia in patients who undergoing major thoracotomy.</p><p><strong>Methods: </strong>Patients with ASA I-III, aged between 18 and 65 years scheduled for major thoracotomy were enrolled. Patients were randomly assigned to receive an intravenous (IV) infusion of placebo combined with ESP block using placebo (group P), ESP block with 0.25% bupivacaine combined with IV placebo (group ESPB), or IV-lidocaine combined with ESP-block using placebo (group L). The primary outcome was postoperative (24 h) total opioid consumption. The secondary outcomes were VAS scores, rescue analgesia, and intraoperative remifentanil consumption.</p><p><strong>Results: </strong>Resting VAS scores were significantly lower in both groups ESPB and L compared to group P during the first four postoperative hours. Similarly, dynamic VAS scores were lower in group ESPB and group L compared to group P during the first two postoperative hours (p < 0.05). ESP block was not found to be superior to systemic lidocaine in reducing morphine requirements during the first 24 h (30.25 ± 5.1 vs. 28.7 ± 3.1 respectively, p = 0.567). Additionally, the difference in morphine consumption between group P and either ESP-block or systemic lidocaine groups was minimal, amounting to only 3-4.5 mg. However, the requirement for rescue analgesia was significantly lower in both groups ESPB and L compared to group P (p < 0.05). There was no difference between groups ESPB and L in terms of rescue analgesia requirement.</p><p><strong>Conclusion: </strong>ESP block did not demonstrate superior postoperative analgesic efficacy compared to systemic lidocaine in patients undergoing major thoracotomy.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"45-53"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144208240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognosis, imaging characteristics, and clinicopathological features of heavy smokers with clinical stage I lung adenocarcinoma: a multicenter study. 重度吸烟者合并临床I期肺腺癌的预后、影像学特征和临床病理特征:一项多中心研究
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-01 Epub Date: 2025-06-10 DOI: 10.1007/s11748-025-02166-7
Ikki Takada, Yoshihisa Shimada, Takahiro Mimae, Yujin Kudo, Takuya Nagashima, Yoshihiro Miyata, Hiroyuki Ito, Morihito Okada, Norihiko Ikeda

Objective: This study aimed to elucidate the relationship between smoking extent and prognosis, imaging characteristics, and clinicopathological factors in patients with clinical stage I lung adenocarcinoma (c-stage I LDA).

Methods: We evaluated 2,285 patients who underwent surgical resection for c-stage I LDA between 2010 and 2018. Patients were classified into three groups based on the Brinkman Index (BI): never smokers (BI = 0), light smokers (0 < BI ≤ 600), and heavy smokers (BI > 600). Clinicopathological features and prognosis were analyzed according to smoking extent.

Results: Significant differences in overall survival (OS) were observed across the smoking groups. Heavy smokers exhibited more invasive imaging characteristics, including a larger solid proportion and a higher maximum standardized uptake value (SUVmax), compared to never and light smokers. In multivariable analyses, heavy smoking was significantly associated with poorer OS (hazard ratio [HR] 2.071, p < 0.001). In addition, older age (HR 1.111, p < 0 .001) and the presence of vascular invasion (HR 2.312, p < 0.001) were also associated with worse OS among heavy smokers.

Conclusion: Smoking extent was independently associated with poorer survival, larger solid tumor size, and higher SUVmax in patients with c-stage I LDA. Age and vascular invasion emerged as strong prognostic factors, particularly among heavy smokers.

目的:探讨临床I期肺腺癌(c-stage LDA)患者吸烟程度与预后、影像学特征及临床病理因素的关系。方法:我们评估了2010年至2018年期间接受手术切除c期I期LDA的2,285例患者。根据Brinkman指数(BI)将患者分为从不吸烟者(BI = 0)和轻度吸烟者(BI = 0 600)三组。根据吸烟程度分析临床病理特征及预后。结果:吸烟组的总生存期(OS)有显著差异。与从不吸烟者和轻度吸烟者相比,重度吸烟者表现出更多的侵入性影像学特征,包括更大的固体比例和更高的最大标准化摄取值(SUVmax)。在多变量分析中,重度吸烟与较差的生存期显著相关(危险比[HR] 2.071, p)。结论:吸烟程度与c期LDA患者较差的生存期、较大的实体瘤大小和较高的SUVmax独立相关。年龄和血管侵入成为重要的预后因素,特别是在重度吸烟者中。
{"title":"Prognosis, imaging characteristics, and clinicopathological features of heavy smokers with clinical stage I lung adenocarcinoma: a multicenter study.","authors":"Ikki Takada, Yoshihisa Shimada, Takahiro Mimae, Yujin Kudo, Takuya Nagashima, Yoshihiro Miyata, Hiroyuki Ito, Morihito Okada, Norihiko Ikeda","doi":"10.1007/s11748-025-02166-7","DOIUrl":"10.1007/s11748-025-02166-7","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to elucidate the relationship between smoking extent and prognosis, imaging characteristics, and clinicopathological factors in patients with clinical stage I lung adenocarcinoma (c-stage I LDA).</p><p><strong>Methods: </strong>We evaluated 2,285 patients who underwent surgical resection for c-stage I LDA between 2010 and 2018. Patients were classified into three groups based on the Brinkman Index (BI): never smokers (BI = 0), light smokers (0 < BI ≤ 600), and heavy smokers (BI > 600). Clinicopathological features and prognosis were analyzed according to smoking extent.</p><p><strong>Results: </strong>Significant differences in overall survival (OS) were observed across the smoking groups. Heavy smokers exhibited more invasive imaging characteristics, including a larger solid proportion and a higher maximum standardized uptake value (SUVmax), compared to never and light smokers. In multivariable analyses, heavy smoking was significantly associated with poorer OS (hazard ratio [HR] 2.071, p < 0.001). In addition, older age (HR 1.111, p < 0 .001) and the presence of vascular invasion (HR 2.312, p < 0.001) were also associated with worse OS among heavy smokers.</p><p><strong>Conclusion: </strong>Smoking extent was independently associated with poorer survival, larger solid tumor size, and higher SUVmax in patients with c-stage I LDA. Age and vascular invasion emerged as strong prognostic factors, particularly among heavy smokers.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"65-72"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12789097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144257818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unilateral upper lung field pulmonary fibrosis after primary lung cancer surgery as a late complication to be recognized. 单侧肺上野肺纤维化作为原发性肺癌手术后的晚期并发症有待认识。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-01 Epub Date: 2025-06-06 DOI: 10.1007/s11748-025-02164-9
Hironori Ishibashi, Mariko Hanafusa, Ayaka Asakawa, Yuya Ishikawa, Ryo Wakejima, Shota Horibe, Kenichi Okubo

Objective: Unilateral upper lung field pulmonary fibrosis (UPF) is a possible complication on the operated side after lung cancer surgery. However, its incidence and associated perioperative factors remain unclear. This study investigated the clinical characteristics of patients with unilateral UPF after primary lung cancer surgery.

Methods: We reviewed the records of all consecutive patients with lung cancer who underwent complete resection at the Institute of Science, Tokyo, between July 2010 and December 2021. We estimated the cumulative incidence and sub-hazard ratios using competing risk regression models.

Results: A total of 979 patients were included in this analysis. The median follow-up period up to the last follow-up was 59.2 months (interquartile range 37.0-84.6 months). With 39 (4.0%) cases of postoperative unilateral UPF, the median follow-up time until the diagnosis of unilateral UPF was 25.5 months (interquartile range 12.9-45.3 months), and the 3-, 5-, and 10-year cumulative incidences of unilateral UPF were 2.7%, 4.0%, and 5.4%, respectively. The 5-year overall survival rate was 87.3%; however, 30 of the 39 patients (76.9%) with unilateral UPF experienced subsequent complications related to unilateral UPF, such as progressive respiratory distress, progressive body weight loss, and pneumonia. Age > 75 years, male sex, low body mass index (< 20 kg/m2), ischemic heart disease, history of pneumonia, emphysema, pulmonary apical cap, and right lower lobe tumors are possible risk factors for unilateral UPF.

Conclusions: Unilateral UPF is an unrecognized late complication of lung cancer surgery that should be carefully monitored in patients with risk factors.

目的:单侧上肺野肺纤维化(UPF)是肺癌术后手术侧可能出现的并发症。然而,其发病率和相关围手术期因素尚不清楚。本研究探讨原发性肺癌手术后单侧UPF患者的临床特点。方法:我们回顾了2010年7月至2021年12月期间在东京科学研究所接受完全切除的所有连续肺癌患者的记录。我们使用竞争风险回归模型估计累积发生率和亚风险比。结果:本分析共纳入979例患者。截至最后一次随访的中位随访期为59.2个月(四分位数间距37.0-84.6个月)。39例(4.0%)术后单侧UPF中位随访时间为25.5个月(四分位数间距12.9-45.3个月),单侧UPF 3年、5年和10年累计发病率分别为2.7%、4.0%和5.4%。5年总生存率为87.3%;然而,39例单侧UPF患者中有30例(76.9%)出现了与单侧UPF相关的后续并发症,如进行性呼吸窘迫、进行性体重减轻和肺炎。年龄bb ~ 75岁、男性、低体重指数(2)、缺血性心脏病、肺炎、肺气肿、肺顶、右下叶肿瘤史是单侧UPF的可能危险因素。结论:单侧UPF是肺癌手术中一种未被发现的晚期并发症,在有危险因素的患者中应仔细监测。
{"title":"Unilateral upper lung field pulmonary fibrosis after primary lung cancer surgery as a late complication to be recognized.","authors":"Hironori Ishibashi, Mariko Hanafusa, Ayaka Asakawa, Yuya Ishikawa, Ryo Wakejima, Shota Horibe, Kenichi Okubo","doi":"10.1007/s11748-025-02164-9","DOIUrl":"10.1007/s11748-025-02164-9","url":null,"abstract":"<p><strong>Objective: </strong>Unilateral upper lung field pulmonary fibrosis (UPF) is a possible complication on the operated side after lung cancer surgery. However, its incidence and associated perioperative factors remain unclear. This study investigated the clinical characteristics of patients with unilateral UPF after primary lung cancer surgery.</p><p><strong>Methods: </strong>We reviewed the records of all consecutive patients with lung cancer who underwent complete resection at the Institute of Science, Tokyo, between July 2010 and December 2021. We estimated the cumulative incidence and sub-hazard ratios using competing risk regression models.</p><p><strong>Results: </strong>A total of 979 patients were included in this analysis. The median follow-up period up to the last follow-up was 59.2 months (interquartile range 37.0-84.6 months). With 39 (4.0%) cases of postoperative unilateral UPF, the median follow-up time until the diagnosis of unilateral UPF was 25.5 months (interquartile range 12.9-45.3 months), and the 3-, 5-, and 10-year cumulative incidences of unilateral UPF were 2.7%, 4.0%, and 5.4%, respectively. The 5-year overall survival rate was 87.3%; however, 30 of the 39 patients (76.9%) with unilateral UPF experienced subsequent complications related to unilateral UPF, such as progressive respiratory distress, progressive body weight loss, and pneumonia. Age > 75 years, male sex, low body mass index (< 20 kg/m<sup>2</sup>), ischemic heart disease, history of pneumonia, emphysema, pulmonary apical cap, and right lower lobe tumors are possible risk factors for unilateral UPF.</p><p><strong>Conclusions: </strong>Unilateral UPF is an unrecognized late complication of lung cancer surgery that should be carefully monitored in patients with risk factors.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"54-64"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12789182/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144233814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new strategy for open surgery of giant aortoiliac aneurysms with preservation of the hypogastric artery. 保留腹下动脉的巨大髂主动脉动脉瘤开放手术新策略。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-01 Epub Date: 2025-07-08 DOI: 10.1007/s11748-025-02179-2
Dragan Piljic, Nail Sehic, Jus Ksela, Mario Lescan

Purpose: We present a new approach for open surgical repair of giant aortoiliac (AI) aneurysms that prioritizes preservation of the hypogastric artery (HA). In cases where the aneurysm extends to the iliac bifurcation and involves both HAs, traditional open repair techniques often require an aortobifemoral bypass with HA exclusion, posing challenges for maintaining pelvic perfusion.

Methods: A retrospective analysis of 10 patients treated between 07/2021 and 07/2023 was conducted. The aneurysms extended to both HA in all cases. Patients were followed up at 30-day and in 6-month intervals thereafter. A total of 10 HA revascularization procedures were performed in 10 patients undergoing open surgical AI aneurysms repair (9 men and 1 woman; median age 68 [65; 70] years). Six-mm polyester grafts were used for aortic tube graft to HA bypass in 10 cases.

Results: Successful open surgical repair of giant AI aneurysms, including those involving the iliac bifurcation, was achieved in all cases. There was one case of perioperative myocardial infarction with pulmonary edema. No instances of gluteal claudication, colon ischemia, or perineal ischemia were observed. Eight patients reported no change in sexual function, while one patient experienced a reduction in erectile function. One patient died in the ICU 2 weeks postoperatively. During a follow-up period of 6-18 months, graft patency was maintained in nine patients.

Conclusion: An additional branch to the HA can reliably maintain pelvic circulation in the short to intermediate term, helping to prevent ischemia in patients requiring extended open surgical repair that involves both HAs.

目的:我们提出了一种新的开放手术修复巨大髂主动脉(AI)动脉瘤的方法,优先保留腹下动脉(HA)。当动脉瘤延伸至髂分叉并累及两个HA时,传统的开放式修复技术通常需要主动脉股动脉旁路手术并排除HA,这对维持盆腔灌注提出了挑战。方法:回顾性分析2021年7月至2023年7月收治的10例患者。所有病例的动脉瘤均延伸至双HA。患者每隔30天和6个月随访一次。在10例接受开放性人工动脉瘤修复术的患者中,共进行了10次HA血运重建术(9男1女;中位年龄68岁[65岁;70年)。10例采用6mm聚酯片主动脉导管移植HA分流术。结果:所有病例均成功完成了包括髂分叉在内的巨大AI动脉瘤的开放手术修复。围手术期心肌梗死合并肺水肿1例。没有观察到臀跛行、结肠缺血或会阴缺血的情况。8名患者报告性功能没有变化,而1名患者勃起功能下降。1例患者术后2周在ICU死亡。在6-18个月的随访期间,9例患者保持移植物通畅。结论:HA的一个额外分支可以在短期到中期可靠地维持盆腔循环,有助于防止需要延长开放手术修复的患者缺血。
{"title":"A new strategy for open surgery of giant aortoiliac aneurysms with preservation of the hypogastric artery.","authors":"Dragan Piljic, Nail Sehic, Jus Ksela, Mario Lescan","doi":"10.1007/s11748-025-02179-2","DOIUrl":"10.1007/s11748-025-02179-2","url":null,"abstract":"<p><strong>Purpose: </strong>We present a new approach for open surgical repair of giant aortoiliac (AI) aneurysms that prioritizes preservation of the hypogastric artery (HA). In cases where the aneurysm extends to the iliac bifurcation and involves both HAs, traditional open repair techniques often require an aortobifemoral bypass with HA exclusion, posing challenges for maintaining pelvic perfusion.</p><p><strong>Methods: </strong>A retrospective analysis of 10 patients treated between 07/2021 and 07/2023 was conducted. The aneurysms extended to both HA in all cases. Patients were followed up at 30-day and in 6-month intervals thereafter. A total of 10 HA revascularization procedures were performed in 10 patients undergoing open surgical AI aneurysms repair (9 men and 1 woman; median age 68 [65; 70] years). Six-mm polyester grafts were used for aortic tube graft to HA bypass in 10 cases.</p><p><strong>Results: </strong>Successful open surgical repair of giant AI aneurysms, including those involving the iliac bifurcation, was achieved in all cases. There was one case of perioperative myocardial infarction with pulmonary edema. No instances of gluteal claudication, colon ischemia, or perineal ischemia were observed. Eight patients reported no change in sexual function, while one patient experienced a reduction in erectile function. One patient died in the ICU 2 weeks postoperatively. During a follow-up period of 6-18 months, graft patency was maintained in nine patients.</p><p><strong>Conclusion: </strong>An additional branch to the HA can reliably maintain pelvic circulation in the short to intermediate term, helping to prevent ischemia in patients requiring extended open surgical repair that involves both HAs.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"23-27"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skeletal muscle volume by 3D imaging and long-term survival in esophageal squamous cell carcinoma with neoadjuvant chemotherapy. 食道鳞状细胞癌新辅助化疗后骨骼肌体积三维成像与远期生存率的关系。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-01 Epub Date: 2025-09-22 DOI: 10.1007/s11748-025-02201-7
Yuto Maeda, Keisuke Kosumi, Hiroki Tsubakihara, Yoshihiro Hara, Kojiro Eto, Satoshi Ida, Yuji Miyamoto, Naoya Yoshida, Masaaki Iwatsuki

Background: Neoadjuvant chemotherapy (NAC) is commonly administered to improve long-term survival in patients with locally advanced esophageal squamous cell carcinoma (ESCC). This study investigated the impact of perioperative skeletal muscle index (SMI), assessed by 3D imaging, on survival outcomes.

Methods: We retrospectively reviewed 139 ESCC patients who underwent surgical resection following NAC. SMI was measured pre- and post-NAC using 3D imaging. Patients were stratified into quartiles based on post-NAC SMI, and survival outcomes were evaluated.

Results: Patients in the lowest SMI quartile (Q1) were more likely to develop postoperative pneumonia and had significantly worse 3-year overall survival (OS) and relapse-free survival (RFS) compared with those in Q2-Q4 (P < 0.01). Multivariate analysis identified low SMI as an independent predictor of poor OS (HR: 3.22; 95% CI: 1.86-5.57; P < 0.01).

Conclusions: Low SMI after NAC, as assessed by 3D imaging, is an independent predictor of poor survival in ESCC patients. These findings highlight the importance of muscle preservation and precise 3D evaluation before surgery.

背景:新辅助化疗(NAC)通常用于改善局部晚期食管鳞状细胞癌(ESCC)患者的长期生存。本研究通过3D成像评估围手术期骨骼肌指数(SMI)对生存结果的影响。方法:我们回顾性分析了139例接受NAC手术切除的ESCC患者。采用三维成像技术测量nac前后的SMI。根据nac后的SMI将患者分为四分位数,并评估生存结果。结果:与Q2-Q4的患者相比,最低SMI四分位数(Q1)的患者更容易发生术后肺炎,3年总生存期(OS)和无复发生存期(RFS)明显更差(P)。结论:通过3D成像评估,NAC后低SMI是ESCC患者生存不良的独立预测因子。这些发现强调了术前肌肉保存和精确3D评估的重要性。
{"title":"Skeletal muscle volume by 3D imaging and long-term survival in esophageal squamous cell carcinoma with neoadjuvant chemotherapy.","authors":"Yuto Maeda, Keisuke Kosumi, Hiroki Tsubakihara, Yoshihiro Hara, Kojiro Eto, Satoshi Ida, Yuji Miyamoto, Naoya Yoshida, Masaaki Iwatsuki","doi":"10.1007/s11748-025-02201-7","DOIUrl":"10.1007/s11748-025-02201-7","url":null,"abstract":"<p><strong>Background: </strong>Neoadjuvant chemotherapy (NAC) is commonly administered to improve long-term survival in patients with locally advanced esophageal squamous cell carcinoma (ESCC). This study investigated the impact of perioperative skeletal muscle index (SMI), assessed by 3D imaging, on survival outcomes.</p><p><strong>Methods: </strong>We retrospectively reviewed 139 ESCC patients who underwent surgical resection following NAC. SMI was measured pre- and post-NAC using 3D imaging. Patients were stratified into quartiles based on post-NAC SMI, and survival outcomes were evaluated.</p><p><strong>Results: </strong>Patients in the lowest SMI quartile (Q1) were more likely to develop postoperative pneumonia and had significantly worse 3-year overall survival (OS) and relapse-free survival (RFS) compared with those in Q2-Q4 (P < 0.01). Multivariate analysis identified low SMI as an independent predictor of poor OS (HR: 3.22; 95% CI: 1.86-5.57; P < 0.01).</p><p><strong>Conclusions: </strong>Low SMI after NAC, as assessed by 3D imaging, is an independent predictor of poor survival in ESCC patients. These findings highlight the importance of muscle preservation and precise 3D evaluation before surgery.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"87-96"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145112603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
General Thoracic and Cardiovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1